![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Hls Therapeutics | TSXV:HLS | TSX Venture | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 14.10 | 14.00 | 14.49 | 0 | 01:00:00 |
TORONTO, March 16, 2018 /CNW/ - Bill Wells, Executive Chairman of the Board, HLS Therapeutics Inc. (HLS), joined Tim Babcock, Director, Listed Issuer Services, TSX Venture Exchange, to open the market. HLS Therapeutics Inc. is a specialty pharmaceutical company focused on the acquisition and commercialization of late stage development, commercial stage promoted and established stage branded pharmaceutical products in the North American markets. HLS Therapeutics Inc. commenced trading on TSX Venture Exchange on March 14, 2018.
SOURCE TMX Group Limited
Copyright 2018 Canada NewsWire
1 Year Hls Therapeutics Chart |
1 Month Hls Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions